Trial · NCT02581631
Participant flow25
How many started, completed or left each group, period by period.
1 to 20 of 25
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Diffuse Large B-cell Lymphoma (DLBCL) | 42 | |
| Overall Study | STARTED | Peripheral T-cell Lymphoma (PTCL) | 33 | |
| Overall Study | STARTED | Cutaneous T-cell Lymphoma (CTCL) | 29 | |
| Overall Study | STARTED | Mediastinal Grey Zone Lymphoma (MGZL) | 10 | |
| Overall Study | STARTED | Primary Mediastinal B-cell Lymphoma (PMBL) | 30 | |
| Overall Study | Phase 1 DLT Evaluable Participants | Diffuse Large B-cell Lymphoma (DLBCL) | 2 | |
| Overall Study | Phase 1 DLT Evaluable Participants | Peripheral T-cell Lymphoma (PTCL) | 1 | |
| Overall Study | Phase 1 DLT Evaluable Participants | Cutaneous T-cell Lymphoma (CTCL) | 3 | |
| Overall Study | Phase 1 DLT Evaluable Participants | Mediastinal Grey Zone Lymphoma (MGZL) | 0 | |
| Overall Study | Phase 1 DLT Evaluable Participants | Primary Mediastinal B-cell Lymphoma (PMBL) | 0 | |
| Overall Study | Completed Phase 1 DLT Evaluation | Diffuse Large B-cell Lymphoma (DLBCL) | 2 | |
| Overall Study | Completed Phase 1 DLT Evaluation | Peripheral T-cell Lymphoma (PTCL) | 1 | |
| Overall Study | Completed Phase 1 DLT Evaluation | Cutaneous T-cell Lymphoma (CTCL) | 3 | |
| Overall Study | Completed Phase 1 DLT Evaluation | Mediastinal Grey Zone Lymphoma (MGZL) | 0 | |
| Overall Study | Completed Phase 1 DLT Evaluation | Primary Mediastinal B-cell Lymphoma (PMBL) | 0 | |
| Overall Study | COMPLETED | Diffuse Large B-cell Lymphoma (DLBCL) | 0 | |
| Overall Study | COMPLETED | Peripheral T-cell Lymphoma (PTCL) | 0 | |
| Overall Study | COMPLETED | Cutaneous T-cell Lymphoma (CTCL) | 0 | |
| Overall Study | COMPLETED | Mediastinal Grey Zone Lymphoma (MGZL) | 0 | |
| Overall Study | COMPLETED | Primary Mediastinal B-cell Lymphoma (PMBL) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02581631/flow